Chronic diseases are a burden for companion animals, but can be managed better if diagnosed early. Multi-omics analysis is complex, but offers opportunities to discover novel biomarker panels.
A global animal health pharmaceutical company has amassed significant molecular data & continues to acquire new data assets rapidly. This has escalated its bioinformatics demands and introduced both data management challenges & opportunities, which they require expert guidance to navigate.
Audited existing scientific workflows to deliver a comprehensive re-engineering implementation plan
Refactored five independent analysis tools into robust, production-quality code by bridging scientific expertise with software best practices
Engineered a unified pipeline to connect in-house and external software into one coherent workflow
Deployed a robust Nextflow architecture to seamlessly orchestrate and scale the unified scientific workflows
Embedded these integrated workflows directly into the client’s custom cloud-based business orchestration layer
Delivered a comprehensive testing strategy and rigorous documentation to fully support Computerized System Validation (CSV)
Let’s discuss how we can turn your data into real scientific impact.
Contact us >
For over a century, the life sciences industry has relied on animal models as the standard for predicting drug safety and effect. But today, the industry faces a harsh reality: over 90% of new drugs that appear safe and effective in animal tests ultimately fail in human clinical trials (see for example Ineichen et al. 2024 [1] and Marshall et al. 2023[2])
Oncology drug development often begins in patients, allowing early safety and efficacy insights. Yet many cancer drugs still fail in the clinic. We validate the target but ignore its context within the tumor microenvironment. This article explores why spatial biology may improve clinical success.
BioLizard has been named “Bioinformatics Innovation of the Year” in the 2025 BioTech Breakthrough Awards. The honor spotlights Bio|Verse® Navigator, a visual analytics workspace that unifies complex R&D data so scientists can decide faster, with confidence.